Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and Insulin Resistance

levonorgestrel has been researched along with Insulin Resistance in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19902 (10.00)18.7374
1990's4 (20.00)18.2507
2000's2 (10.00)29.6817
2010's9 (45.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F1
Abdulkareem, TO; Adegoke, TE; Adeyanju, OA; Dibia, C; Michael, OS; Olatunji, LA; Omotoye, OO; Oyabambi, AO; Sabinari, IW; Usman, TO1
Anoka, NA; Lawrence, OA; Olufunmilayo, OM; Olufunto, BO1
Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO1
Abolarinwa, BA; Achile, CJ; Kim, IK; Olaniyi, KS; Olatunji, LA; Usman, TO1
Michael, OS; Olatunji, LA1
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO1
Michael, OS; Olatunji, LA; Omolekulo, TE1
Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD1
Olaniyi, KS; Olatunji, LA1
Bender, NM; Mishell, DR; Montoro, M; Najera, SO; Segall-Gutierrez, P; Stanczyk, FZ1
Franks, S; Hartikainen, AL; Järvelin, MR; Laitinen, J; Leinonen, M; Martikainen, H; McCarthy, MI; Morin-Papunen, L; Pouta, A; Ruokonen, A; Sovio, U1
Beasley, A; Estes, C; Guerrero, J; Westhoff, C1
Koopersmith, TB; Lobo, RA1
Laatikainen, T; Raudaskoski, T; Tomás, C1
Biswas, A; Coeling Bennink, HJ; Korver, T; Ratnam, SS; Viegas, OA1
Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V1
Hager, SR; Kalkhoff, RK1
Godsland, I; Wynn, V1
Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO1

Trials

4 trial(s) available for levonorgestrel and Insulin Resistance

ArticleYear
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
    BMJ open diabetes research & care, 2020, Volume: 8, Issue:1

    Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome

2020
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
    Contraception, 2012, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult

2012
Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Contraception, 1995, Volume: 51, Issue:3

    Topics: Administration, Cutaneous; Adolescent; Adult; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Drug Implants; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Radioimmunoassay

1995
Implanon contraceptive implants: effects on carbohydrate metabolism.
    Contraception, 2001, Volume: 63, Issue:3

    Topics: Adolescent; Adult; Blood Glucose; Contraceptive Agents, Female; Desogestrel; Drug Implants; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Kinetics; Levonorgestrel; Vinyl Compounds

2001

Other Studies

16 other study(ies) available for levonorgestrel and Insulin Resistance

ArticleYear
Allopurinol and valproic acid improve cardiac triglyceride and Na
    Archives of physiology and biochemistry, 2022, Volume: 128, Issue:5

    Topics: Adenosine Triphosphatases; Aldosterone; Allopurinol; Animals; Contraceptives, Oral, Combined; Female; Glucose Intolerance; Humans; Insulin Resistance; Levonorgestrel; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Triglycerides; Valproic Acid

2022
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
    Environmental toxicology and pharmacology, 2020, Volume: 79

    Topics: Animals; Contraceptives, Oral, Combined; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Glucocorticoids; Glucosephosphate Dehydrogenase; Insulin Resistance; Levonorgestrel; Maternal-Fetal Exchange; Myocardium; Pregnancy; Progestins; Rats, Wistar

2020
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley

2017
Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.
    Environmental toxicology and pharmacology, 2017, Volume: 52

    Topics: Animals; Blood Pressure; C-Reactive Protein; Cardiomegaly; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Insulin Resistance; Levonorgestrel; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats, Wistar; Uric Acid

2017
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
    Archives of physiology and biochemistry, 2018, Volume: 124, Issue:2

    Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar

2018
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides

2018
Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.
    Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:1

    Topics: Adenosine Deaminase; Animals; Dipeptidyl Peptidase 4; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Insulin Resistance; Levonorgestrel; Liver; Rats, Wistar; Sodium Acetate; Triglycerides; Uric Acid; Xanthine Oxidase

2019
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
    Scientific reports, 2019, 07-15, Volume: 9, Issue:1

    Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; India; Inflammation; Insulin; Insulin Resistance; Levonorgestrel; Metformin; Polycystic Ovary Syndrome; Risk Factors; Waist-Hip Ratio; Young Adult

2019
Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
    Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:11

    Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glucosephosphate Dehydrogenase; Glycogen; Hyperinsulinism; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Lipid Peroxidation; Liver; Protein Kinases; Rats; Rats, Wistar; Uric Acid

2019
Effects of progestin-only long-acting contraception on metabolic markers in obese women.
    Contraception, 2013, Volume: 88, Issue:3

    Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Desogestrel; Fasting; Female; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intrauterine Devices, Medicated; Levonorgestrel; Metabolic Syndrome; Obesity; Progestins; Prospective Studies; Waist Circumference

2013
Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:5

    Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Inflammation; Insulin; Insulin Resistance; Intrauterine Devices, Medicated; Leukocyte Count; Levonorgestrel; Lipids; Lipoproteins, HDL; Metabolic Diseases; Progestins; Waist-Hip Ratio

2008
Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
    Acta obstetricia et gynecologica Scandinavica, 1999, Volume: 78, Issue:6

    Topics: Administration, Cutaneous; Blood Glucose; C-Peptide; Estradiol; Female; Hormone Replacement Therapy; Humans; Hysterectomy; Insulin; Insulin Resistance; Levonorgestrel; Middle Aged; Postmenopause; Progesterone Congeners

1999
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:1

    Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes

1992
Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1990, Volume: 22, Issue:5

    Topics: Animals; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Glucose; Hindlimb; Insulin; Insulin Antagonists; Insulin Resistance; Levonorgestrel; Muscles; Norethindrone; Norgestrel; Phenylalanine; Progesterone Congeners; Rats; Rats, Inbred Strains

1990
Effects of oral contraceptives on carbohydrate metabolism.
    The Journal of reproductive medicine, 1986, Volume: 31, Issue:9 Suppl

    Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norethindrone; Norgestrel

1986
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:3

    Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics

1987